Palisade Asset Management’s Surmodics SRDX Stock Holding History
Bought
Maintained
Sold
Other funds holding SRDX
Palisade Asset Management's SRDX Position: Q4 2025 in Review
Palisade Asset Management sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 2,000 shares — an estimated $59.8K sold.
Palisade Asset Management first reported a position in SRDX in Q3 2025 and held it in 1 quarter. The position peaked at $59.8K in Q3 2025. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.
- Palisade Asset Management reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
- Palisade Asset Management sold 2,000 Surmodics shares in Q4 2025, an estimated $59.8K.
- Palisade Asset Management first reported a position in Surmodics in Q3 2025 and held it in 1 quarter.
- Palisade Asset Management's Surmodics position peaked at $59.8K in Q3 2025.
- 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.
Based on Palisade Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.